CRISPR Medicine News

Researchers have engineered probiotic bacteria to produce CRISPR-Cas9 and edit the ROS-generating...

COPENHAGEN, Denmark, August 3, 2026 — CRISPR Medicine News (CMN) and the Chinese Society of Gene &...

An IGI-led consortium has received up to $27.7 million from ARPA-H to develop personalised in vivo...

Three boys with Duchenne muscular dystrophy retained broadly stable motor function one year after...

A six-year-old girl died after receiving an experimental CRISPR-Cas base-editing treatment for a...

Some of the best links we picked up around the internet

A new artificial intelligence–guided strategy can design highly divergent yet functional variants of...

A new review examines how CRISPR–Cas9 genome editing, artificial intelligence and personalised...

Some of the best links we picked up around the internet

A search for new CRISPR enzymes to improve crop breeding has unexpectedly led to a new strategy for...

Epicrispr Biotechnologies has completed enrolment and dose escalation in the first-in-human trial of...

Preliminary Phase 1 data from Fate Therapeutics indicate that its off-the-shelf CAR T-cell therapy,...

Researchers at Ghent University have engineered virus-like particles decorated with anti-CD4...

Sangamo Therapeutics researchers have engineered the serine integrase Bxb1 to insert large DNA...

Researchers have used CRISPR base editing to identify a previously unknown regulatory mechanism in...

Researchers in Denmark have used CRISPR-Cas9 genome editing to generate T cells expressing a...

A perspective article in Nature Reviews Bioengineering outlines how CRISPR-based RNA silencing could...

Some of the best links we picked up around the internet

The first approved CRISPR medicine has now shown similarly strong results in children as young as...

Beam Therapeutics has received U.S. FDA clearance of its Investigational New Drug (IND) application...

Some of the best links we picked up around the internet

Addressing manufacturing bottlenecks in the transition to clinical scale.

A single intravenous dose of Intellia Therapeutics’ in vivo CRISPR-Cas9 therapy lonvoguran...

Updated phase 1 data indicate that a single infusion of Caribou Biosciences' CB-011, an allogeneic...

Researchers have developed a new prime-editing screening platform that substantially improves...

A new CRISPR-based strategy turns cancer cells' own mutant transcripts against them, opening a...

Researchers have reported the first use of CRISPR-derived base editing to make precise DNA changes...

Early clinical results suggest that FT836, an off-the-shelf CAR T-cell therapy derived from induced...

Alpha-1 antitrypsin deficiency (AATD) has turned into the most crowded proving ground in genetic...

AIRNA has taken a different route to correcting the genetic lesion behind alpha-1 antitrypsin...

CRISPRMED27 brings together the global CRISPR and gene editing ecosystem for four days of scientific...

Updated Phase 1 data presented at the 2026 American Society of Gene and Cell Therapy (ASGCT) meeting...

When clinicians at the Children’s Hospital of Philadelphia (CHOP) treated baby KJ – born with a...

Intellia Therapeutics has initiated a rolling biologics license application (BLA) with the U.S. Food...

A new regulatory framework proposed in February by the US Food and Drug Administration could...

A genome-wide CRISPR-Cas9 loss-of-function screening platform developed for primary human natural...

A new study from Stanford University combines CRISPR activation with single-cell and spatial...

A Chinese research team has developed TIGER (Template-Independent Genome Editing for Restoration), a...

Some of the best links we picked up around the internet

Scribe Therapeutics is preparing to take its first cardiometabolic programme into the clinic in...

A hybrid CRISPR design pipeline improves the predictability of genome editing outcomes in mouse...

Some of the best links we picked up around the internet

One or two years ago, if you had proposed lipid nanoparticles (LNPs) as an RNA delivery system for...

A new study develops a pyrethroid-resistant Aedes aegypti strain carrying a Cas9 transgene, enabling...